The Experts below are selected from a list of 15063 Experts worldwide ranked by ideXlab platform
Adrienne L Davis - One of the best experts on this subject based on the ideXlab platform.
-
caregivers Willingness to Accept expedited vaccine research during the covid 19 pandemic a cross sectional survey
Clinical Therapeutics, 2020Co-Authors: Ran D Goldman, Shashidhar R Marneni, Michelle Seiler, Julie C Brown, Eileen J Klein, Cristina Parra Cotanda, Renana Gelernter, Tyler Yan, Julia Hoeffe, Adrienne L DavisAbstract:PURPOSE: This study determined the predictors of caregivers' Willingness to Accept an accelerated regulatory process for the development of vaccines against coronavirus disease 2019 (COVID-19). METHODS: An international cross-sectional survey was administered to 2557 caregivers of children in 17 pediatric emergency departments (EDs) across 6 countries from March 26, 2020, to June 30, 2020. Caregivers were asked to select 1 of 4 choices with which they most agreed regarding a proposed COVID-19 vaccine-approval process, in addition to questions regarding demographic characteristics, the ED visit, and attitudes about COVID-19. Univariate analyses were conducted using the Mann-Whitney U test for comparing non-normally distributed continuous variables, an independent t test for comparing normally distributed continuous variables, and a χ2 or Fisher exact test for categorical variables. Multivariate logistic regression analysis was used for determining independent factors associated with caregivers' Willingness to Accept abridged development of a COVID-19 vaccine. A P value of <0.05 was considered significant. FINDINGS: Almost half (1101/2557; 43%) of caregivers reported that they were willing to Accept less rigorous testing and postresearch approval of a new COVID-19 vaccine. Independent factors associated with caregivers' Willingness to Accept expedited COVID-19 vaccine research included having children who were up to date on the vaccination schedule (odds ratio [OR] = 1.72; 95% CI, 1.29-2.31), caregivers' concern about having had COVID-19 themselves at the time of survey completion in the ED (OR = 1.1; 95% CI, 1.05-1.16), and caregivers' intent to have their children vaccinated against COVID-19 if a vaccine were to become available (OR = 1.84; 95% CI, 1.54-2.21). Compared with fathers, mothers completing the survey were less likely to approve of changes in the vaccine-development process (OR = 0.641; 95% CI, 0.529-0.775). IMPLICATIONS: Less than half of caregivers in this worldwide sample were willing to Accept abbreviated COVID-19 vaccine testing. As a part of an effort to increase Acceptance and uptake of a new vaccine, especially in order to protect children, public health strategies and individual providers should understand caregivers' attitudes toward the approval of a vaccine and consult them appropriately.
-
caregivers Willingness to Accept expedited vaccine research during the covid 19 pandemic a cross sectional survey
Clinical Therapeutics, 2020Co-Authors: Ran D Goldman, Shashidhar R Marneni, Michelle Seiler, Julie C Brown, Eileen J Klein, Cristina Parra Cotanda, Renana Gelernter, Tyler Yan, Julia Hoeffe, Adrienne L DavisAbstract:Abstract Purpose This study determined the predictors of caregivers' Willingness to Accept an accelerated regulatory process for the development of vaccines against coronavirus disease 2019 (COVID-19). Methods An international cross-sectional survey was administered to 2557 caregivers of children in 17 pediatric emergency departments (EDs) across 6 countries from March 26, 2020, to June 30, 2020. Caregivers were asked to select 1 of 4 choices with which they most agreed regarding a proposed COVID-19 vaccine–approval process, in addition to questions regarding demographic characteristics, the ED visit, and attitudes about COVID-19. Univariate analyses were conducted using the Mann–Whitney U test for comparing non–normally distributed continuous variables, an independent t test for comparing normally distributed continuous variables, and a χ2 or Fisher exact test for categorical variables. Multivariate logistic regression analysis was used for determining independent factors associated with caregivers' Willingness to Accept abridged development of a COVID-19 vaccine. A P value of Findings Almost half (1101/2557; 43%) of caregivers reported that they were willing to Accept less rigorous testing and postresearch approval of a new COVID-19 vaccine. Independent factors associated with caregivers' Willingness to Accept expedited COVID-19 vaccine research included having children who were up to date on the vaccination schedule (odds ratio [OR] = 1.72; 95% CI, 1.29–2.31), caregivers' concern about having had COVID-19 themselves at the time of survey completion in the ED (OR = 1.1; 95% CI, 1.05–1.16), and caregivers' intent to have their children vaccinated against COVID-19 if a vaccine were to become available (OR = 1.84; 95% CI, 1.54–2.21). Compared with fathers, mothers completing the survey were less likely to approve of changes in the vaccine-development process (OR = 0.641; 95% CI, 0.529–0.775). Implications Less than half of caregivers in this worldwide sample were willing to Accept abbreviated COVID-19 vaccine testing. As a part of an effort to increase Acceptance and uptake of a new vaccine, especially in order to protect children, public health strategies and individual providers should understand caregivers' attitudes toward the approval of a vaccine and consult them appropriately.
Ran D Goldman - One of the best experts on this subject based on the ideXlab platform.
-
caregivers Willingness to Accept expedited vaccine research during the covid 19 pandemic a cross sectional survey
Clinical Therapeutics, 2020Co-Authors: Ran D Goldman, Shashidhar R Marneni, Michelle Seiler, Julie C Brown, Eileen J Klein, Cristina Parra Cotanda, Renana Gelernter, Tyler Yan, Julia Hoeffe, Adrienne L DavisAbstract:PURPOSE: This study determined the predictors of caregivers' Willingness to Accept an accelerated regulatory process for the development of vaccines against coronavirus disease 2019 (COVID-19). METHODS: An international cross-sectional survey was administered to 2557 caregivers of children in 17 pediatric emergency departments (EDs) across 6 countries from March 26, 2020, to June 30, 2020. Caregivers were asked to select 1 of 4 choices with which they most agreed regarding a proposed COVID-19 vaccine-approval process, in addition to questions regarding demographic characteristics, the ED visit, and attitudes about COVID-19. Univariate analyses were conducted using the Mann-Whitney U test for comparing non-normally distributed continuous variables, an independent t test for comparing normally distributed continuous variables, and a χ2 or Fisher exact test for categorical variables. Multivariate logistic regression analysis was used for determining independent factors associated with caregivers' Willingness to Accept abridged development of a COVID-19 vaccine. A P value of <0.05 was considered significant. FINDINGS: Almost half (1101/2557; 43%) of caregivers reported that they were willing to Accept less rigorous testing and postresearch approval of a new COVID-19 vaccine. Independent factors associated with caregivers' Willingness to Accept expedited COVID-19 vaccine research included having children who were up to date on the vaccination schedule (odds ratio [OR] = 1.72; 95% CI, 1.29-2.31), caregivers' concern about having had COVID-19 themselves at the time of survey completion in the ED (OR = 1.1; 95% CI, 1.05-1.16), and caregivers' intent to have their children vaccinated against COVID-19 if a vaccine were to become available (OR = 1.84; 95% CI, 1.54-2.21). Compared with fathers, mothers completing the survey were less likely to approve of changes in the vaccine-development process (OR = 0.641; 95% CI, 0.529-0.775). IMPLICATIONS: Less than half of caregivers in this worldwide sample were willing to Accept abbreviated COVID-19 vaccine testing. As a part of an effort to increase Acceptance and uptake of a new vaccine, especially in order to protect children, public health strategies and individual providers should understand caregivers' attitudes toward the approval of a vaccine and consult them appropriately.
-
caregivers Willingness to Accept expedited vaccine research during the covid 19 pandemic a cross sectional survey
Clinical Therapeutics, 2020Co-Authors: Ran D Goldman, Shashidhar R Marneni, Michelle Seiler, Julie C Brown, Eileen J Klein, Cristina Parra Cotanda, Renana Gelernter, Tyler Yan, Julia Hoeffe, Adrienne L DavisAbstract:Abstract Purpose This study determined the predictors of caregivers' Willingness to Accept an accelerated regulatory process for the development of vaccines against coronavirus disease 2019 (COVID-19). Methods An international cross-sectional survey was administered to 2557 caregivers of children in 17 pediatric emergency departments (EDs) across 6 countries from March 26, 2020, to June 30, 2020. Caregivers were asked to select 1 of 4 choices with which they most agreed regarding a proposed COVID-19 vaccine–approval process, in addition to questions regarding demographic characteristics, the ED visit, and attitudes about COVID-19. Univariate analyses were conducted using the Mann–Whitney U test for comparing non–normally distributed continuous variables, an independent t test for comparing normally distributed continuous variables, and a χ2 or Fisher exact test for categorical variables. Multivariate logistic regression analysis was used for determining independent factors associated with caregivers' Willingness to Accept abridged development of a COVID-19 vaccine. A P value of Findings Almost half (1101/2557; 43%) of caregivers reported that they were willing to Accept less rigorous testing and postresearch approval of a new COVID-19 vaccine. Independent factors associated with caregivers' Willingness to Accept expedited COVID-19 vaccine research included having children who were up to date on the vaccination schedule (odds ratio [OR] = 1.72; 95% CI, 1.29–2.31), caregivers' concern about having had COVID-19 themselves at the time of survey completion in the ED (OR = 1.1; 95% CI, 1.05–1.16), and caregivers' intent to have their children vaccinated against COVID-19 if a vaccine were to become available (OR = 1.84; 95% CI, 1.54–2.21). Compared with fathers, mothers completing the survey were less likely to approve of changes in the vaccine-development process (OR = 0.641; 95% CI, 0.529–0.775). Implications Less than half of caregivers in this worldwide sample were willing to Accept abbreviated COVID-19 vaccine testing. As a part of an effort to increase Acceptance and uptake of a new vaccine, especially in order to protect children, public health strategies and individual providers should understand caregivers' attitudes toward the approval of a vaccine and consult them appropriately.
Julia Hoeffe - One of the best experts on this subject based on the ideXlab platform.
-
caregivers Willingness to Accept expedited vaccine research during the covid 19 pandemic a cross sectional survey
Clinical Therapeutics, 2020Co-Authors: Ran D Goldman, Shashidhar R Marneni, Michelle Seiler, Julie C Brown, Eileen J Klein, Cristina Parra Cotanda, Renana Gelernter, Tyler Yan, Julia Hoeffe, Adrienne L DavisAbstract:PURPOSE: This study determined the predictors of caregivers' Willingness to Accept an accelerated regulatory process for the development of vaccines against coronavirus disease 2019 (COVID-19). METHODS: An international cross-sectional survey was administered to 2557 caregivers of children in 17 pediatric emergency departments (EDs) across 6 countries from March 26, 2020, to June 30, 2020. Caregivers were asked to select 1 of 4 choices with which they most agreed regarding a proposed COVID-19 vaccine-approval process, in addition to questions regarding demographic characteristics, the ED visit, and attitudes about COVID-19. Univariate analyses were conducted using the Mann-Whitney U test for comparing non-normally distributed continuous variables, an independent t test for comparing normally distributed continuous variables, and a χ2 or Fisher exact test for categorical variables. Multivariate logistic regression analysis was used for determining independent factors associated with caregivers' Willingness to Accept abridged development of a COVID-19 vaccine. A P value of <0.05 was considered significant. FINDINGS: Almost half (1101/2557; 43%) of caregivers reported that they were willing to Accept less rigorous testing and postresearch approval of a new COVID-19 vaccine. Independent factors associated with caregivers' Willingness to Accept expedited COVID-19 vaccine research included having children who were up to date on the vaccination schedule (odds ratio [OR] = 1.72; 95% CI, 1.29-2.31), caregivers' concern about having had COVID-19 themselves at the time of survey completion in the ED (OR = 1.1; 95% CI, 1.05-1.16), and caregivers' intent to have their children vaccinated against COVID-19 if a vaccine were to become available (OR = 1.84; 95% CI, 1.54-2.21). Compared with fathers, mothers completing the survey were less likely to approve of changes in the vaccine-development process (OR = 0.641; 95% CI, 0.529-0.775). IMPLICATIONS: Less than half of caregivers in this worldwide sample were willing to Accept abbreviated COVID-19 vaccine testing. As a part of an effort to increase Acceptance and uptake of a new vaccine, especially in order to protect children, public health strategies and individual providers should understand caregivers' attitudes toward the approval of a vaccine and consult them appropriately.
-
caregivers Willingness to Accept expedited vaccine research during the covid 19 pandemic a cross sectional survey
Clinical Therapeutics, 2020Co-Authors: Ran D Goldman, Shashidhar R Marneni, Michelle Seiler, Julie C Brown, Eileen J Klein, Cristina Parra Cotanda, Renana Gelernter, Tyler Yan, Julia Hoeffe, Adrienne L DavisAbstract:Abstract Purpose This study determined the predictors of caregivers' Willingness to Accept an accelerated regulatory process for the development of vaccines against coronavirus disease 2019 (COVID-19). Methods An international cross-sectional survey was administered to 2557 caregivers of children in 17 pediatric emergency departments (EDs) across 6 countries from March 26, 2020, to June 30, 2020. Caregivers were asked to select 1 of 4 choices with which they most agreed regarding a proposed COVID-19 vaccine–approval process, in addition to questions regarding demographic characteristics, the ED visit, and attitudes about COVID-19. Univariate analyses were conducted using the Mann–Whitney U test for comparing non–normally distributed continuous variables, an independent t test for comparing normally distributed continuous variables, and a χ2 or Fisher exact test for categorical variables. Multivariate logistic regression analysis was used for determining independent factors associated with caregivers' Willingness to Accept abridged development of a COVID-19 vaccine. A P value of Findings Almost half (1101/2557; 43%) of caregivers reported that they were willing to Accept less rigorous testing and postresearch approval of a new COVID-19 vaccine. Independent factors associated with caregivers' Willingness to Accept expedited COVID-19 vaccine research included having children who were up to date on the vaccination schedule (odds ratio [OR] = 1.72; 95% CI, 1.29–2.31), caregivers' concern about having had COVID-19 themselves at the time of survey completion in the ED (OR = 1.1; 95% CI, 1.05–1.16), and caregivers' intent to have their children vaccinated against COVID-19 if a vaccine were to become available (OR = 1.84; 95% CI, 1.54–2.21). Compared with fathers, mothers completing the survey were less likely to approve of changes in the vaccine-development process (OR = 0.641; 95% CI, 0.529–0.775). Implications Less than half of caregivers in this worldwide sample were willing to Accept abbreviated COVID-19 vaccine testing. As a part of an effort to increase Acceptance and uptake of a new vaccine, especially in order to protect children, public health strategies and individual providers should understand caregivers' attitudes toward the approval of a vaccine and consult them appropriately.
Tyler Yan - One of the best experts on this subject based on the ideXlab platform.
-
caregivers Willingness to Accept expedited vaccine research during the covid 19 pandemic a cross sectional survey
Clinical Therapeutics, 2020Co-Authors: Ran D Goldman, Shashidhar R Marneni, Michelle Seiler, Julie C Brown, Eileen J Klein, Cristina Parra Cotanda, Renana Gelernter, Tyler Yan, Julia Hoeffe, Adrienne L DavisAbstract:PURPOSE: This study determined the predictors of caregivers' Willingness to Accept an accelerated regulatory process for the development of vaccines against coronavirus disease 2019 (COVID-19). METHODS: An international cross-sectional survey was administered to 2557 caregivers of children in 17 pediatric emergency departments (EDs) across 6 countries from March 26, 2020, to June 30, 2020. Caregivers were asked to select 1 of 4 choices with which they most agreed regarding a proposed COVID-19 vaccine-approval process, in addition to questions regarding demographic characteristics, the ED visit, and attitudes about COVID-19. Univariate analyses were conducted using the Mann-Whitney U test for comparing non-normally distributed continuous variables, an independent t test for comparing normally distributed continuous variables, and a χ2 or Fisher exact test for categorical variables. Multivariate logistic regression analysis was used for determining independent factors associated with caregivers' Willingness to Accept abridged development of a COVID-19 vaccine. A P value of <0.05 was considered significant. FINDINGS: Almost half (1101/2557; 43%) of caregivers reported that they were willing to Accept less rigorous testing and postresearch approval of a new COVID-19 vaccine. Independent factors associated with caregivers' Willingness to Accept expedited COVID-19 vaccine research included having children who were up to date on the vaccination schedule (odds ratio [OR] = 1.72; 95% CI, 1.29-2.31), caregivers' concern about having had COVID-19 themselves at the time of survey completion in the ED (OR = 1.1; 95% CI, 1.05-1.16), and caregivers' intent to have their children vaccinated against COVID-19 if a vaccine were to become available (OR = 1.84; 95% CI, 1.54-2.21). Compared with fathers, mothers completing the survey were less likely to approve of changes in the vaccine-development process (OR = 0.641; 95% CI, 0.529-0.775). IMPLICATIONS: Less than half of caregivers in this worldwide sample were willing to Accept abbreviated COVID-19 vaccine testing. As a part of an effort to increase Acceptance and uptake of a new vaccine, especially in order to protect children, public health strategies and individual providers should understand caregivers' attitudes toward the approval of a vaccine and consult them appropriately.
-
caregivers Willingness to Accept expedited vaccine research during the covid 19 pandemic a cross sectional survey
Clinical Therapeutics, 2020Co-Authors: Ran D Goldman, Shashidhar R Marneni, Michelle Seiler, Julie C Brown, Eileen J Klein, Cristina Parra Cotanda, Renana Gelernter, Tyler Yan, Julia Hoeffe, Adrienne L DavisAbstract:Abstract Purpose This study determined the predictors of caregivers' Willingness to Accept an accelerated regulatory process for the development of vaccines against coronavirus disease 2019 (COVID-19). Methods An international cross-sectional survey was administered to 2557 caregivers of children in 17 pediatric emergency departments (EDs) across 6 countries from March 26, 2020, to June 30, 2020. Caregivers were asked to select 1 of 4 choices with which they most agreed regarding a proposed COVID-19 vaccine–approval process, in addition to questions regarding demographic characteristics, the ED visit, and attitudes about COVID-19. Univariate analyses were conducted using the Mann–Whitney U test for comparing non–normally distributed continuous variables, an independent t test for comparing normally distributed continuous variables, and a χ2 or Fisher exact test for categorical variables. Multivariate logistic regression analysis was used for determining independent factors associated with caregivers' Willingness to Accept abridged development of a COVID-19 vaccine. A P value of Findings Almost half (1101/2557; 43%) of caregivers reported that they were willing to Accept less rigorous testing and postresearch approval of a new COVID-19 vaccine. Independent factors associated with caregivers' Willingness to Accept expedited COVID-19 vaccine research included having children who were up to date on the vaccination schedule (odds ratio [OR] = 1.72; 95% CI, 1.29–2.31), caregivers' concern about having had COVID-19 themselves at the time of survey completion in the ED (OR = 1.1; 95% CI, 1.05–1.16), and caregivers' intent to have their children vaccinated against COVID-19 if a vaccine were to become available (OR = 1.84; 95% CI, 1.54–2.21). Compared with fathers, mothers completing the survey were less likely to approve of changes in the vaccine-development process (OR = 0.641; 95% CI, 0.529–0.775). Implications Less than half of caregivers in this worldwide sample were willing to Accept abbreviated COVID-19 vaccine testing. As a part of an effort to increase Acceptance and uptake of a new vaccine, especially in order to protect children, public health strategies and individual providers should understand caregivers' attitudes toward the approval of a vaccine and consult them appropriately.
Cristina Parra Cotanda - One of the best experts on this subject based on the ideXlab platform.
-
caregivers Willingness to Accept expedited vaccine research during the covid 19 pandemic a cross sectional survey
Clinical Therapeutics, 2020Co-Authors: Ran D Goldman, Shashidhar R Marneni, Michelle Seiler, Julie C Brown, Eileen J Klein, Cristina Parra Cotanda, Renana Gelernter, Tyler Yan, Julia Hoeffe, Adrienne L DavisAbstract:PURPOSE: This study determined the predictors of caregivers' Willingness to Accept an accelerated regulatory process for the development of vaccines against coronavirus disease 2019 (COVID-19). METHODS: An international cross-sectional survey was administered to 2557 caregivers of children in 17 pediatric emergency departments (EDs) across 6 countries from March 26, 2020, to June 30, 2020. Caregivers were asked to select 1 of 4 choices with which they most agreed regarding a proposed COVID-19 vaccine-approval process, in addition to questions regarding demographic characteristics, the ED visit, and attitudes about COVID-19. Univariate analyses were conducted using the Mann-Whitney U test for comparing non-normally distributed continuous variables, an independent t test for comparing normally distributed continuous variables, and a χ2 or Fisher exact test for categorical variables. Multivariate logistic regression analysis was used for determining independent factors associated with caregivers' Willingness to Accept abridged development of a COVID-19 vaccine. A P value of <0.05 was considered significant. FINDINGS: Almost half (1101/2557; 43%) of caregivers reported that they were willing to Accept less rigorous testing and postresearch approval of a new COVID-19 vaccine. Independent factors associated with caregivers' Willingness to Accept expedited COVID-19 vaccine research included having children who were up to date on the vaccination schedule (odds ratio [OR] = 1.72; 95% CI, 1.29-2.31), caregivers' concern about having had COVID-19 themselves at the time of survey completion in the ED (OR = 1.1; 95% CI, 1.05-1.16), and caregivers' intent to have their children vaccinated against COVID-19 if a vaccine were to become available (OR = 1.84; 95% CI, 1.54-2.21). Compared with fathers, mothers completing the survey were less likely to approve of changes in the vaccine-development process (OR = 0.641; 95% CI, 0.529-0.775). IMPLICATIONS: Less than half of caregivers in this worldwide sample were willing to Accept abbreviated COVID-19 vaccine testing. As a part of an effort to increase Acceptance and uptake of a new vaccine, especially in order to protect children, public health strategies and individual providers should understand caregivers' attitudes toward the approval of a vaccine and consult them appropriately.
-
caregivers Willingness to Accept expedited vaccine research during the covid 19 pandemic a cross sectional survey
Clinical Therapeutics, 2020Co-Authors: Ran D Goldman, Shashidhar R Marneni, Michelle Seiler, Julie C Brown, Eileen J Klein, Cristina Parra Cotanda, Renana Gelernter, Tyler Yan, Julia Hoeffe, Adrienne L DavisAbstract:Abstract Purpose This study determined the predictors of caregivers' Willingness to Accept an accelerated regulatory process for the development of vaccines against coronavirus disease 2019 (COVID-19). Methods An international cross-sectional survey was administered to 2557 caregivers of children in 17 pediatric emergency departments (EDs) across 6 countries from March 26, 2020, to June 30, 2020. Caregivers were asked to select 1 of 4 choices with which they most agreed regarding a proposed COVID-19 vaccine–approval process, in addition to questions regarding demographic characteristics, the ED visit, and attitudes about COVID-19. Univariate analyses were conducted using the Mann–Whitney U test for comparing non–normally distributed continuous variables, an independent t test for comparing normally distributed continuous variables, and a χ2 or Fisher exact test for categorical variables. Multivariate logistic regression analysis was used for determining independent factors associated with caregivers' Willingness to Accept abridged development of a COVID-19 vaccine. A P value of Findings Almost half (1101/2557; 43%) of caregivers reported that they were willing to Accept less rigorous testing and postresearch approval of a new COVID-19 vaccine. Independent factors associated with caregivers' Willingness to Accept expedited COVID-19 vaccine research included having children who were up to date on the vaccination schedule (odds ratio [OR] = 1.72; 95% CI, 1.29–2.31), caregivers' concern about having had COVID-19 themselves at the time of survey completion in the ED (OR = 1.1; 95% CI, 1.05–1.16), and caregivers' intent to have their children vaccinated against COVID-19 if a vaccine were to become available (OR = 1.84; 95% CI, 1.54–2.21). Compared with fathers, mothers completing the survey were less likely to approve of changes in the vaccine-development process (OR = 0.641; 95% CI, 0.529–0.775). Implications Less than half of caregivers in this worldwide sample were willing to Accept abbreviated COVID-19 vaccine testing. As a part of an effort to increase Acceptance and uptake of a new vaccine, especially in order to protect children, public health strategies and individual providers should understand caregivers' attitudes toward the approval of a vaccine and consult them appropriately.
